CDC confirms Dr. Anne Schuchat as acting director

Anne Schuchat, MD, will succeed outgoing CDC director Tom Frieden, MD, who is set to hand in his resignation on Friday, according to WebMD Health News.

Advertisement

Dr. Schuchat will serve as interim director of the CDC until the incoming HHS secretary official appoints a new director. President-elect Donald Trump has nominated Congressman Tom Price (Ga.-R) for the post.

Dr. Schuchat joined the agency in 1988 as an epidemic intelligence service officer. She has served under Dr. Frieden as principal deputy director of the CDC since September 2015.

In her time at the CDC, Dr. Schuchat also served on the agency’s anthrax emergency response team during the 2001 anthrax attacks in the U.S. Internationally, she has worked in West Africa on vaccine trials for multiple diseases — including Ebola — and in China during Beijing’s SARS emergency response to an outbreak that began in 2002.

The new interim director has authored or co-authored more than 230 scientific articles, book chapters and reviews. She will be the third woman ever to lead the agency.

More articles on infection control: 
Englewood Hospital to test employees, patients for lead 
New Hampshire health officials warn of surging gonorrhea rates 
CDC invests millions in antibiotic resistance efforts — where did the money go?

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.